anti-ANG2 monoclonal antibody MEDI-3617
Term · Oncology and biomedicine · MLC-T-ONC-010123
A fully human IgG1 monoclonal antibody against angiopoietin 2 (ANG2), with potential antiangiogenic activity. Anti-ANG2 monoclonal antibody MEDI-3617 binds to Ang2 and interferes with the interaction between Ang2 and its receptor TEK tyrosine kinase (Tie2), thereby resulting in the disruption of vascular remodeling. This may inhibit angiogenesis and may eventually lead to an inhibition of tumor cell proliferation.
| Identifier | MLC-T-ONC-010123 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | anti-ANG2 MoAb MEDI-3617 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010123",
"term": "anti-ANG2 monoclonal antibody MEDI-3617",
"field": "Oncology and biomedicine",
"definition": "A fully human IgG1 monoclonal antibody against angiopoietin 2 (ANG2), with potential antiangiogenic activity. Anti-ANG2 monoclonal antibody MEDI-3617 binds to Ang2 and interferes with the interaction between Ang2 and its receptor TEK tyrosine kinase (Tie2), thereby resulting in the disruption of vascular remodeling. This may inhibit angiogenesis and may eventually lead to an inhibition of tumor cell proliferation.",
"abbreviation": "anti-ANG2 MoAb MEDI-3617",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-ang2-monoclonal-antibody-medi-3617/"
}
Record 1,191 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.